A concerning new analysis reveals the Trump administration's plan to dismantle 2024 regulations on ethylene oxide (EtO) pollution represents a direct assault on environmental justice and public health. This move seeks to curtail the Environmental Protection Agency's (EPA) power to safeguard communities from hazardous emissions, potentially unleashing more of this potent carcinogen into the air, particularly impacting marginalized populations.

Recent scientific findings have established that EtO is approximately 60 times more carcinogenic than previously understood when the last regulations were developed in 2006, a fact the Trump administration seemingly disregards. The Biden EPA, in 2024, implemented a critical rule mandating a 90% reduction in EtO emissions from facilities across the nation, a crucial step in protecting public health. The proposed rescission would effectively nullify these gains, perpetuating the disproportionate burden of toxic air pollution on low-income neighborhoods, often communities of color.

A Harvard analysis exposes the administration's strategy to restrict the EPA's ability to strengthen regulations even when faced with alarming new scientific evidence regarding hazardous air pollutants. This sets a dangerous precedent, undermining the agency's core mission to protect public health and the environment.

If the Trump EPA succeeds in its legal challenge, nearly eight tons of EtO would continue to be released annually, jeopardizing the health of vulnerable communities and making it significantly more difficult for the EPA to enact future protections against toxic air pollution. Erik Olson, senior advisor with the Natural Resources Defense Council (NRDC) action fund, rightly points out that this rollback is part of a broader, deeply troubling effort to weaken controls on toxic chemicals, particularly carcinogens, signaling a disregard for the well-being of American citizens.

Public health advocates emphasize the structural deficiencies in chemical regulation, where industry claims are often accepted with minimal scrutiny, and independent science takes years to uncover the true risks. The case of EtO exemplifies this problem, highlighting the need for robust and proactive regulation, not deregulation that prioritizes industry profits over public health. Ethylene oxide is used to sterilize approximately 20 billion medical devices annually, including pacemakers and syringes, underscoring its importance in healthcare. However, this utility cannot justify exposing communities to a known carcinogen linked to leukemia and other serious health issues. Rescinding the 2024 rule would leave an estimated 2.3 million people exposed to the toxic gas.